Evidence map›Paper›PMID 40530332›Full record

ArticleFrontiers in cell and developmental biology2025

Deep spatial sequencing revealing differential immune responses in human hepatocellular carcinoma.

Yan-Ping Yu, Caroline Obert, Bao-Guo Ren, Marielle Krivit, Kyle Metcalfe, Jia-Jun Liu, Tuval Ben-Yehezkel, Silvia Liu, Jian-Hua Luo

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Yan-Ping YuDepartments of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Caroline ObertElement Biosciences Inc., San Diego, CA, United States.
Bao-Guo RenDepartments of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Marielle KrivitElement Biosciences Inc., San Diego, CA, United States.
Kyle MetcalfeElement Biosciences Inc., San Diego, CA, United States.
Jia-Jun LiuDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Tuval Ben-YehezkelElement Biosciences Inc., San Diego, CA, United States.
Silvia LiuDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Jian-Hua LuoDepartments of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR001857 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2016 to 2025
$129.3M
Pittsburgh Liver Research CenterP30DK120531 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Shuchang Silvia Liu · 2019 to 2026
$10.9M
Genome targeting of liver cancerR56CA229262 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LUO, JIANHUA · 2018 to 2019
$705k
High-Throughput Computing for Genomics and Bioinformatics ResearchS10OD028483 · OD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEE, ADRIAN V · 2021 to 2021
$574k
NCATS NIH HHS UL1 TR001857NCI NIH HHS R56 CA229262NIDDK NIH HHS P30 DK120531NIH HHS S10 OD028483
6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is one of the most lethal cancers for humans. HCC is highly heterogeneous. In this study, we performed ultra-depth (∼1 million reads per spot) sequencing of 6,320 spatial transcriptomes on a case of HCC. Sixteen distinct spatial expression clusters were identified. Each of these clusters was spatially contiguous and had distinct gene expression patterns. In contrast, benign liver tissues showed minimal heterogeneity in terms of gene expression. Numerous immune cell-enriched spots were identified in both HCC and benign liver regions. Cells adjacent to these immune cell-enriched spots showed significant alterations in their gene expression patterns. Interestingly, the responses of HCC cells to the nearby immune cells were significantly more intense and broader, while the responses of benign liver cells to immune cells were somewhat narrow and muted, suggesting an innate difference in immune cell activities towards HCC cells in comparison with benign liver cells. However, cell-cell interaction analyses showed significant immune evasion by HCC cancer cells. When standard-depth sequencing was performed, significant numbers of genes and pathways that were associated with these changes disappeared. Qualitative differences in some pathways were also found. These results suggest that deep spatial sequencing may help to uncover previously unidentified mechanisms of liver cancer development.

Indexed as

cancer microenvironmentcell-cell interactionHCCimmune responsesultra-depth spatial sequencing

Identifiers

PMID40530332
PMCPMC12170511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.